Rodman & Renshaw Reiterates Buy on Emergent BioSolutions, Maintains $16 Price Target
Emergent BioSolutions Analyst Ratings
Emergent Biosolutions Price Target Announced at $16.00/Share by Rodman & Renshaw
Rodman & Renshaw Initiates Coverage On Emergent BioSolutions With Buy Rating, Announces Price Target of $16
Emergent BioSolutions Analyst Ratings
Rodman & Renshawはエマージェント バイオソリューションズ(EBS.US)のレーティングを強気に引き上げ、目標株価を16ドルに引き下げた
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target
Emergent BioSolutions Analyst Ratings
Emergent BioSolutions Analyst Ratings
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target
Emergent BioSolutions Analyst Ratings
Emergent BioSolutions Analyst Ratings
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target
Emergent BioSolutions Analyst Ratings
Emergent BioSolutions Analyst Ratings
Benchmark Upgrades Emergent BioSolutions to Buy, Announces $5 Price Target
Emergent BioSolutions Analyst Ratings